Journal of Molecular and Cellular Cardiology
Volume 43, Issue 2 , Pages 177-186 , August 2007

Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure

  • Halvor K. Mørk

      Affiliations

    • Institute for Experimental Medical Research, Ullevaal University Hospital, Oslo, Norway
    • Centre for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway
    • Corresponding Author InformationCorresponding author. Institute for Experimental Medical Research, 4. etg. Kirurgisk Bygning, Ullevaal University Hospital, 0407 Oslo, Norway. Tel.: +47 23 016 843; fax: +47 23 016 799.
    • ,
  • Ivar Sjaastad

      Affiliations

    • Institute for Experimental Medical Research, Ullevaal University Hospital, Oslo, Norway
    • Centre for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway
    • Department of Cardiology, Ullevaal University Hospital, Oslo, Norway
    • ,
  • Jørn B. Sande

      Affiliations

    • Institute for Experimental Medical Research, Ullevaal University Hospital, Oslo, Norway
    • Centre for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway
    • Simula Research Laboratory, Lysaker, Norway
    • ,
  • Muthu Periasamy

      Affiliations

    • Department of Physiology and Cell Biology, The Ohio State University College of Medicine and Public Health, Columbus, OH 43210, USA
    • ,
  • Ole M. Sejersted

      Affiliations

    • Institute for Experimental Medical Research, Ullevaal University Hospital, Oslo, Norway
    • Centre for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway
    • ,
  • William E. Louch

      Affiliations

    • Institute for Experimental Medical Research, Ullevaal University Hospital, Oslo, Norway
    • Centre for Heart Failure Research, Faculty of Medicine, University of Oslo, Oslo, Norway

Received 11 January 2007 ,Revised 30 March 2007 ,Accepted 9 May 2007.

References 

  1. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J. Mol. Cell. Cardiol. 2002;34:951–969
  2. Chu G, Haghighi K, Kranias EG. From mouse to man: understanding heart failure through genetically altered mouse models. J. Card. Fail. 2002;8:S432–S449
  3. Hellermann JP, Jacobsen SJ, Redfield MM, Reeder GS, Weston SA, Roger VL. Heart failure after myocardial infarction: clinical presentation and survival. Eur. J. Heart Fail. 2005;7:119–125
  4. Zhang R, Khoo MSC, Wu Y, Yang Y, Grueter CE, Ni G, et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 2005;11:409–417
  5. Louch WE, Mork HK, Sexton J, Stromme TA, Laake P, Sjaastad I, et al. T-tubule disorganization and reduced synchrony of Ca2+ release in murine cardiomyocytes following myocardial infarction. J. Physiol. (London). 2006;574:519–533
  6. Woldbaek PR, Hoen IB, Christensen G, Tonnesen T. Gene expression of colony-stimulating factors and stem cell factor after myocardial infarction in the mouse. Acta Physiol. Scand. 2002;175:173–181
  7. Finsen AV, Christensen G, Sjaastad I. Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse. J. Appl. Physiol. 2005;98:680–689
  8. Thomas MJ, Sjaastad I, Andersen K, Helm PJ, Wasserstrom JA, Sejersted OM, et al. Localization and function of the Na+/Ca2+-exchanger in normal and detubulated rat cardiomyocytes. J. Mol. Cell. Cardiol. 2003;35:1325–1337
  9. Huke S, Periasamy M. Phosphorylation-status of phospholamban and calsequestrin modifies their affinity towards commonly used antibodies. J. Mol. Cell. Cardiol. 2004;37:795–799
  10. Yuan J, Reed A, Chen F, Stewart CN. Statistical analysis of real-time PCR data. BMC Bioinformatics. 2006;7:85
  11. Bondarenko VE, Szigeti GP, Bett GCL, Kim SJ, Rasmusson RL. Computer model of action potential of mouse ventricular myocytes. Am. J. Physiol. 2004;287:H1378–H1403
  12. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046–1055
  13. Piacentino V, Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM, et al. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ. Res. 2003;92:651–658
  14. Vangheluwe P, Tjwa M, Van Den Bergh A, Louch WE, Beullens M, Dode L, et al. A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span. J. Mol. Cell. Cardiol. 2006;41:308–317
  15. Antoons G, Mubagwa K, Nevelsteen I, Sipido KR. Mechanisms underlying the frequency dependence of contraction and [Ca2+]i transients in mouse ventricular myocytes. J. Physiol. (Online). 2002;543:889–898
  16. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, et al. Alterations in intracellular calcium handling associated with the inverse force–frequency relation in human dilated cardiomyopathy. Circulation. 1995;92:1169–1178
  17. Siri FM, Krueger J, Nordin C, Ming Z, Aronson RS. Depressed intracellular calcium transients and contraction in myocytes from hypertrophied and failing guinea pig hearts. Am. J. Physiol. 1991;261:H514–H530
  18. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, et al. Defective excitation–contraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997;276:800–806
  19. Pieske B, Maier LS, Bers DM, Hasenfuss G. Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ. Res. 1999;85:38–46
  20. Hobai IA, O'Rourke B. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation–contraction coupling in canine heart failure. Circulation. 2001;103:1577–1584
  21. Sande JB, Sjaastad I, Hoen IB, Bokenes J, Tonnessen T, Holt E, et al. Reduced level of serine16 phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc. Res. 2002;53:382–391
  22. Iwanaga Y, Hoshijima M, Gu Y, Iwatate M, Dieterle T, Ikeda Y, et al. Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J. Clin. Invest. 2004;113:727–736
  23. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ. Res. 1994;75:401–409
  24. Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, et al. Chronic phospholamban–sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell. 1999;99:313–322
  25. Kiriazis H, Sato Y, Kadambi VJ, Schmidt AG, Gerst MJ, Hoit BD, et al. Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis. Cardiovasc. Res. 2002;53:372–381
  26. Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Invest. 2003;111:869–876
  27. Bers DM. Excitation–contraction coupling and cardiac contractile force. Second ed.. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2006;
  28. Perrier E, Kerfant BG, Lalevee N, Bideaux P, Rossier MF, Richard S, et al. Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation. 2004;110:776–783
  29. Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, et al. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation. 1998;98:969–976
  30. He JQ, Conklin MW, Foell JD, Wolff MR, Haworth RA, Coronado R, et al. Reduction in density of transverse tubules and L-type Ca2+ channels in canine tachycardia-induced heart failure. Cardiovasc. Res. 2001;49:298–307
  31. Louch WE, Bito V, Heinzel FR, Macianskiene R, Vanhaecke J, Flameng W, et al. Reduced synchrony of Ca2+ release with loss of T-tubules—A comparison to Ca2+ release in human failing cardiomyocytes. Cardiovasc. Res. 2004;62:63–73
  32. Bassani JW, Yuan W, Bers DM. Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am. J. Physiol. 1995;268:C1313–C1319
  33. Sjaastad I, Bokenes J, Swift F, Wasserstrom JA, Sejersted OM. Normal contractions triggered by ICa,L in ventricular myocytes from rats with postinfarction CHF. Am. J. Physiol. 2002;283:H1225–H1236
  34. Sjaastad I, Birkeland JA, Ferrier G, Howlett S, Skomedal T, Bjornerheim R, et al. Defective excitation–contraction coupling in hearts of rats with congestive heart failure. Acta Physiol. Scand. 2005;184:45–58
  35. Yao A, Su Z, Nonaka A, Zubair I, Lu L, Philipson KD, et al. Effects of overexpression of the Na+–Ca2+ exchanger on [Ca2+]i transients in murine ventricular myocytes. Circ. Res. 1998;82:657–665
  36. Quinn FR, Currie S, Duncan AM, Miller S, Sayeed R, Cobbe SM, et al. Myocardial infarction causes increased expression but decreased activity of the myocardial Na+–Ca2+ exchanger in the rabbit. J. Physiol. (London). 2003;553:229–242
  37. Champion HC, Georgakopoulos D, Haldar S, Wang L, Wang Y, Kass DA. Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to study of phospholamban physiology. Circulation. 2003;108:2790–2797
  38. Antoons G, Vangheluwe P, Volders PGA, Bito V, Holemans P, Ceci M, et al. Increased phospholamban phosphorylation limits the force–frequency response in the MLP−/− mouse with heart failure. J. Mol. Cell. Cardiol. 2006;40:350–360
  39. Li L, Chu G, Kranias EG, Bers DM. Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am. J. Physiol.: Heart Circ Physiol. 1998;274:H1335–H1347
  40. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc. Res. 1999;42:270–283
  41. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365–376
  42. Kubalova Z, Terentyev D, Viatchenko-Karpinski S, Nishijima Y, Gyorke I, Terentyeva R, et al. Abnormal intrastore calcium signaling in chronic heart failure. Proc. Natl. Acad. Sci. 2005;102:14104–14109
  43. Sipido KR, Volders PGA, de Groot SHM, Verdonck F, Van de Werf F, Wellens HJJ, et al. Enhanced Ca2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation. 2000;102:2137–2144
  44. Kogler H, Schott P, Toischer K, Milting H, Van PN, Kohlhaas M, et al. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression. Circulation. 2006;113:2724–2732

PII: S0022-2828(07)01042-5

doi: 10.1016/j.yjmcc.2007.05.004

Journal of Molecular and Cellular Cardiology
Volume 43, Issue 2 , Pages 177-186 , August 2007

Article Tools

* Image Usage & Resolution